2021 U.S. Generic and Biosimilar Medicines Savings Report
Sidelined: How Seniors Miss Out On Savings Available Through Generic Substitution
Access Denied: Why New Generics Are Not Reaching America’s Seniors
AAM Securing Sustainable Markets
Medicare and Commercial Plans Fail to Get New Generics to Patients
